Abstract
Interim Analysis of a Phase 2 Study of Bortezomib Plus Rituximab Maintenance Therapy in Patients with Mantle Cell Lymphoma Status Post Autologous Stem Cell Transplantation
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have